Improving Adherence and Outcomes by Artificial Intelligence-Adapted Text Messages (AIM@BP)
|ClinicalTrials.gov Identifier: NCT02454660|
Recruitment Status : Completed
First Posted : May 27, 2015
Last Update Posted : April 11, 2017
|Condition or disease||Intervention/treatment|
|Medication Non-adherence||Behavioral: SMS (Text messages)|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||49 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Improving Adherence and Outcomes by Artificial Intelligence-Adapted Text Messages|
|Actual Study Start Date :||May 2015|
|Primary Completion Date :||November 4, 2016|
|Study Completion Date :||November 4, 2016|
Experimental: SMS (Text messaging)
This group will receive text messages during their entire enrollment period in the study.
Behavioral: SMS (Text messages)
Up to 1 text message a day. The artificial agent will determine whether to send a message each day. If it sends a message, it will also determine which of five message types to send.
No Intervention: No SMS (No text messages)
This group will not receive text messages during their entire enrollment period in the study.
- Medication Adherence (Proportion Days Covered (PDC)) assessed by administrative insurance records [ Time Frame: 2 years ]A measure of Proportion Days Covered (PDC) and is assessed administrative insurance records
- Self-reported medication adherence assessed via a questionnaire [ Time Frame: baseline, 3 months and 9 months ]Medication adherence is collected at these time points and assessed via a questionnaire.
- Pill bottle openings (how often medication was taken) assessed by records from pill bottle caps (MEMS readers) [ Time Frame: 9 months ]proxy measure of how often medication was taken, assessed by records from pill bottle caps (MEMS readers)
- Medication Beliefs assessed via a questionnaire [ Time Frame: baseline, 3 months and 9 months ]A measurement of the patients beliefs about the medication they take will be collected at these time points and assessed via a questionnaire.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02454660
|United States, Michigan|
|University of Michigan College of Pharmacy|
|Ann Arbor, Michigan, United States, 48109|
|Grand Rapids, Michigan, United States, 49503|
|Principal Investigator:||Karen Farris, PhD||Univerity of Michigan, College of Pharmacy|